Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIPDEX: Submucosal vs Intraligamentary Dexamethasone in Symptomatic Irreversible Pulpitis
NCT07672873Recruiting
- Sponsor
- Marmara University
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexamethasone in irreversible pulpitis (3 arms), sponsored by Marmara University. Primary endpoint: Success of Inferior Alveolar Nerve Block Anesthesia. Started Jun 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07672873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07672873.